Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00627133
Other study ID # K17644
Secondary ID
Status Withdrawn
Phase Phase 2
First received
Last updated
Start date February 2008

Study information

Verified date February 2008
Source Medical University of South Carolina
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pilot study to evaluate efficacy of Keppra (levetiracetam) for seizure control in patients with alcohol related seizures.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date February 2008
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria:

- No trauma

- Not pregnant

- No other cause for seizure (hypoglycemia, CNS causes, trauma)

- Good family support

- Working telephone contact

Exclusion Criteria:

- Pregnancy

- Renal failure (creatine > 2mg/dl

- Fever or illness

- Hypotension

- Any trauma

Study Design


Intervention

Drug:
levetiracetam
2 gram iv load, 500mg bid

Locations

Country Name City State
United States Medical University of South Carolina Charleston South Carolina

Sponsors (2)

Lead Sponsor Collaborator
Medical University of South Carolina UCB Pharma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decreased seizures 1, 2, 4, 8 weeks